Treatable disease: Amyotrophic Lateral Sclerosis

Authors

  • Sarisleydis León Núñez Granma Medical University, Manzanillo Faculty
  • Ervin Gómez Matos Granma Medical University, Manzanillo Faculty
  • Leydis García Arévalo Granma Medical University, Manzanillo Faculty
  • Lilia Esther León Vila Granma Medical University
  • Manuel Antonio Céspedes Arrebola Granma Medical University

Keywords:

ALS, amyotrophic lateral sclerosis, neurodegenerative, physiotherapy

Abstract

Insidethe illnesses progressive neurodegenerative she is the amyotrophic lateral sclerosis, considered a devastating illness due to their progressive character of disability that takes to the patient to the death, constituting a problem of health for the tremendous suffering that causes to patient and family. The correct coordination multidisciplinary improvement the quality of the patient's life. They were carried out searches in several sources of information with different terms related with the amyotrophic lateral sclerosis. They will approach the most outstanding in the illness: definition, causes, clinical, diagnostic manifestations, evolution, presage and treatment that the patients will cross. Also, it can be proven the importance that has the correct organization of the multidisciplinary team in the treatment of these patients, being the physiotherapist the most outstanding, because fromprinciple to end is implied in maintaining a functional level and of possible autonomy during the course of the illness.

Downloads

Download data is not yet available.

Downloads

Published

2018-05-25

How to Cite

1.
León Núñez S, Gómez Matos E, García Arévalo L, León Vila LE, Céspedes Arrebola MA. Treatable disease: Amyotrophic Lateral Sclerosis. Revdosdic [Internet]. 2018 May 25 [cited 2025 Mar. 13];1(1 (2018):112-2. Available from: https://revdosdic.sld.cu/index.php/revdosdic/article/view/15

Issue

Vol. 1 No. 1 (2018): JANUARY - MAY

Section

Review Articles

License

Authors who have publications with this journal agree to the following terms: authors retain their copyright and grant the journal the right of first publication of their work, which is simultaneously subject to the Creative Commons Attribution-NonCommercial 4.0 International License that allows third parties to share the work as long as the author and first publication in this journal are indicated, for non-commercial use. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional telematic archive or publishing it in a monographic volume) as long as the initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work via the Internet (e.g., in institutional telematic archives, in their web page or in Pre-print servers) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The Open Access Effect).